Successful treatment of chronic idiopathic neutropenia using recombinant granulocyte colony-stimulating factor

Publisher Website
Google Scholar
Abstract
A patient with chronic idiopathic neutropenia, who had been suffering from repeated infections, was successfully treated with recombinant granulocyte stimulating factor (rhG-CSF). Subcutaneous injection of 30μg/m2 rhG-CSF every two days was sufficient to maintain the neutrophil count at approximately 1,000/μl. The patient has lived without any evidence of infection for the last 10 months using that treatment. There were no side effect caused by rhG-CSF and antibodies against G-CSF were not detected in the patient's plasma.

This publication has 11 references indexed in Scilit: